European Patent Office

T 0625/08 of 25.05.2011

European Case Law Identifier
ECLI:EP:BA:2011:T062508.20110525
Date of decision
25 May 2011
Case number
T 0625/08
Online on
5 July 2011
Petition for review of
-
Application number
96920607.7
IPC class
A61K 31/66
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
Anhydrous alendronate monosodium salt formulations and their use for the treatment of bone diseases
Applicant name
Merck Sharp & Dohme Corp.
Opponent name
Ranbaxy Laboratories Limited
Board
3.3.02
Headnote
-
Relevant legal provisions
European Patent Convention Art 113(2)
Keywords
-
Catchword
-
Cited cases
-
Citing cases
-

ORDER

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The patent is revoked.